DT Cloud Acquisition Corporation Signs Letter of Intent for a Business Combination
New York, New York, Sept. 03, 2024 (GLOBE NEWSWIRE) — DT Cloud Acquisition Corporation (Nasdaq: DYCQU, DYCQ, DYCQR) (the “Company”) […]
Trust Stamp Announces Pricing of Registered Direct Offering and Warrant Inducement, Priced At-The-Market, for Aggregate Gross Proceeds of $2.0 Million
Atlanta, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity Company™ providing AI-powered software used […]
VCI Global Secures Approximately US$18 Million Contract for IPO Deals
KUALA LUMPUR, Malaysia, Sept. 03, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (Frankfurt: H0T) (“VCI Global,” “VCIG,” or […]
Y-mAbs to Participate in Upcoming Investor Conferences in September
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical […]
H&R Block Names Andy Phillips as New Vice President of The Tax Institute
KANSAS CITY, Mo., Sept. 03, 2024 (GLOBE NEWSWIRE) — H&R Block, Inc. (NYSE: HRB), a leading provider of global tax […]
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
AUSTIN, Texas, Sept. 03, 2024 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s […]
Avenue Therapeutics to Participate in Upcoming Investor Conferences
MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company […]
Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference
ATLANTA, Sept. 03, 2024 (GLOBE NEWSWIRE) — Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet […]
Robinhood Markets, Inc. to Present at the Goldman Sachs Communacopia + Technology Conference on September 10, 2024
MENLO PARK, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) — Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will […]
CVRx Announces Appointment of Two New Board Members
MINNEAPOLIS, Sept. 03, 2024 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, today announced the […]
